Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus

Published:2018 Issue:1 Volume:11 Page:2-14
ISSN:1881-641X
Container-title:Annals of Vascular Diseases
language:en
Short-container-title:Annals of Vascular Diseases

Author:

Fujihara Kazuya¹,Sone Hirohito¹

Affiliation:

1. Department of Internal Medicine, Niigata University Faculty of Medicine

Publisher

The Editorial Committee of Annals of Vascular Diseases

Link

https://www.jstage.jst.go.jp/article/avd/11/1/11_ra.17-00109/_pdf

Reference113 articles.

1. 1) IDF Diabetes Atlas 2015 (International Diabetes Federation) (http://www.diabetesatlas.org/). 2015.

2. 2) National Diabetes Fact Sheet, National Center for Chronic Disease Prevention and Health Promotion, US (http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf).

3. 3) Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 2014; 370: 1514-23.

4. 4) Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-8.

5. 5) Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-44.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of diabetes medications in adults with T2D and CVD in Japan: secondary analysis of the CAPTURE study;Diabetology International;2023-06-15

2. Obesity vs. Metabolically Healthy Obesity in East Asia;Encyclopedia;2023-06-12

3. Machine Learning Approach to Drug Treatment Strategy for Diabetes Care;Diabetes & Metabolism Journal;2023-05-31

4. Cardiovascular disease prevalence in adults with type 2 diabetes in Japan: results from the Japanese centers in the CAPTURE study;Diabetology International;2023-01-14

5. The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study;Advances in Therapy;2022-04-21